Lumexa Imaging
Outpatient imaging network with radiologist interpretation and health-system partnerships.
Something off on this page? Send us feedback.
Profile
Provides outpatient diagnostic imaging and radiologist interpretations through locally branded centers, health-system joint ventures and professional-services relationships. Revenue is earned per scan and read, supported by centralized scheduling and authorization plus the Connexia teleradiology network.
Operates an outpatient diagnostic-imaging network through its Outpatient Imaging Center and Professional Services businesses. The first provides MRI, CT, PET, X-ray, ultrasound and mammography, along with radiologist interpretations, from locally branded freestanding centers; the second reads studies for third parties, primarily hospital imaging departments.
Builds regional networks across multiple U.S. markets through health-system joint ventures, acquired platforms and de novo sites, while centralizing scheduling, authorization, technology, procurement, sales and management support. Connexia routes studies to subspecialized radiologists for remote interpretation, supplementing independent radiology practices.
Payment is generally tied to scans and interpretations at government-set or negotiated insurer rates. Operations depend on provider referrals, radiologist and technologist capacity, payor network status and reimbursement, joint-venture governance, clinical regulation, and third-party systems that handle images, scheduling, billing and AI-supported workflows.
Company facts
Key statistics
Year to date −34.5% · Average volume (30d) 463.0K
Analysts
Ratings
Target range
Latest analyst notes
| Date | Firm | Action | Rating | Prior target | Target |
|---|---|---|---|---|---|
| Aug 28, 2026 | Barclays | Reiterate | Overweight | $9 | $13 |
| Aug 13, 2026 | Deutsche Bank | Target | $16 | ||
| May 20, 2026 | Barclays | Target | $9 |
Earnings
EPS
Revenue
History
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Next session |
|---|---|---|---|---|---|---|---|
| Aug 12, 2026Q2 FY26 | $0.15 | $0.20 | +34.9% | $263.1M | $264.2M | +0.4% | +4.01% |
| May 12, 2026Q1 FY26 | $0.12 | $0.18 | +50.0% | $249.5M | $252.5M | +1.2% | −23.33% |
| Mar 26, 2026Q4 FY25 | $0.05 | −$0.38 | −860.0% | $261.2M | $267.7M | +2.5% | +0.39% |
| Dec 3, 2025 | $0.05 | −$0.03 | −176.8% | $261.2M | $260.1M | −0.4% | — |
Financial highlights
| 5 quarters | — | Q4 FY24 | Q1 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | |
|---|---|---|---|---|---|---|---|
| Revenue | — | $248.0M | $245.0M | $267.7M | $252.5M | $264.2M | |
| Gross profit | — | $21.6M | $36.6M | $29.7M | $24.9M | $28.8M | |
| Operating income | — | $15.3M | $10.1M | −$7.5M | $4.5M | $4.4M | |
| Net income | — | −$25.1M | −$7.7M | −$28.7M | $1.7M | $2.7M | |
| Diluted EPS | — | −$0.26 | −$0.08 | −$0.38 | $0.02 | $0.03 | |
| Gross margin | — | 8.7% | 14.9% | 11.1% | 9.8% | 10.9% | |
| Operating margin | — | 6.1% | 4.1% | -2.8% | 1.8% | 1.7% |
Revenue by product · Q2 FY26
Balance sheet, Jun 30, 2026Cash & short-term investments $69.7M · Total debt $975.4M · Total assets $1.81B · Shareholders' equity $615.1M
Dividends
No dividends on record.
Ownership
Shares outstanding 96.08M · Float 95.68M · 99.6% free float
Top shareholders13F · 13D/G · Form 4
| Holder | Shares | % outstanding | Form | Filed |
|---|---|---|---|---|
| Welsh, Carson, Anderson & Stowe XII, L.P. | 70.22M | 74.30% | 13G | Feb 13, 2026 |
| Brown Advisory Inc | 5.84M | 6.08% | 13G | Aug 14, 2026 |
| AllianceBernstein L.P. | 2.98M | 3.10% | 13F | May 15, 2026 |
| Massachusetts Financial Services Co /MA/ | 2.33M | 2.43% | 13F | May 14, 2026 |
| Janus Henderson Group PLC | 2.10M | 2.19% | 13F | May 18, 2026 |
Insider tradesForm 4
Nothing filed in the last 12 months.
View detailsPeers
- RadNet
Largest direct rival in U.S. outpatient diagnostic imaging.
- HCA Healthcare
Large hospital network with diagnostic and freestanding imaging sites.
- Tenet Healthcare
Hospital and ambulatory network with imaging centers and outpatient sites.
CompareAfter-hours close
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Lumexa Imaging | $11.74 | +2.18% | $1.11B | — | 14.6 | 1.1 | — |
| RadNet | $74.61 | −0.05% | $5.87B | — | 110.4 | 2.6 | +25.0% |
| HCA Healthcare | $417.82 | −0.00% | $90.46B | 14.0 | 13.6 | 1.2 | +8.7% |
| Tenet Healthcare | $266.80 | −0.05% | $21.48B | 10.3 | 13.0 | 1.0 | +6.8% |
| Median | 12.1 | 13.6 | 1.2 | +8.7% |






